Speakers
Meet Our Esteemed Speakers
Explore the key opinion leaders and renowned academic experts who bring unparalleled knowledge and thought leadership to our annual events.


Amanda Heslegrave
Senior Research Fellow,
University College London

Brian Lockhart
Head of CDx,
Servier

Cornelia Wilson
Reader and Academic Laboratory Director,
Canterbury Christ Church University

Dirk Kemming
Medical Director Diagnostics Europe,
Daiichi Sankyo Europe

Ed Schuuring
Clinical Scientist in Molecular Pathology,
University Medical Center Groningen

Gunther Jansen
Head of Multimodal Data & Analytics,
Novartis

Joanna Janus
Research Programme Manager,
Cancer Research UK

Marine Garrido
Global Translational Leader,
Bayer

Olga Nissan
Chief Executive Officer,
Protica Bio

Philip Beer
CSO,
Step Pharma

Shashank Saran
Associate Director,
AstraZeneca

Aitana Sogorb-Esteve
Senior Research Fellow,
University College London

Alain Van Gool
Professor Personalized Healthcare,
Radboud University Medical Center

Aliya Sarmanova
Clinical Development Lead Oncology & Genetics,
Roche

Andrew Janowczyk
Assistant Professor,
Emory University

Bernhard Reis
Expert Biomarker & Translational Medicine Leader; Group Head Biomarker Strategy,
F. Hoffman-La Roche Ltd.

Christian Ruiz
Chief Scientific Officer,
University of Basel

Christophe Le Tourneau
Medical Oncologist,
Institut Curie

Dana Mustafa
Assistant Professor & Group Leader,
Erasmus MC

Daniel Keitley
Research Scientist,
Novo Nordisk

Dylan Powell
Assistant Professor in Public Health & Innovation,
Stirling University

Guillaume Desachy
Head Of Biometrics,
Pierre Fabre

Jacques Colinge
Professor,
University of Montpellier, France

Jan Christoph Brase
Global Translational Science Leader,
Bayer

Jehad Charo
Biomarker & Experimental Medicine Leader,
Hoffmann La Roche Ltd

Jun Frederiksen
Director,
Novo Nordisk
.jpg?length=600&name=3f2cbeb3-fb10-44cb-8cef-b7503b52034b-2-11764368speaker_photo-image1-(4).jpg)
Malleswari Challagundla
Senior Scientist II,
AbbVie Deutschland GmbH & Co. KG

Maximilian Breitner
Lab Head Clinical Bioanalytics,
Sandoz
.png?length=600&name=a328609f-2334-45d5-ba4d-4d8c33a896ea-2-11764368speaker_photo-profile-pic-(1).png)
Mohammad Arastoo
Research Fellow,
University of Aberdeen/ TauRx Pharmaceuticals

Nolwen Guigal-Stephan
Head of Clinical Biomaker Development,
Servier Monde

Sina Nassiri
Principal Bioinformatics Scientists & Team Lead,
Roche

Thomas Jensen
Chief Executive Officer,
Allarity Therapeutics

Vinko Tosevski
Senior Director Translational Research,
Immunos Therapeutics

Anand Giddabasappa
Head of Animal Models and Imaging,
Pfizer Inc
Arpita Ray
Principal Scientist,
Genentech

Jean-Francois Martini
Exec. Director, Translational Oncology Lead, Global Product Development - Oncology,
Pfizer
Kristina Mcguire
Executive Director and Head, Precision Medicine Laboratory Operations and Companion Diagnostics,
Regeneron

Kyuho Han
Chief Executive Officer,
MEDiC Life Sciences

Lokesh Agrawal
Program Director,
National Cancer Institute

Robert Getzenberg
Medical Director Diagnostics,
Astellas
Satya Saxena
Director, Global Proteomics, Clinical Pharmacology & Translational Medicine,
Eisai, Inc

Anshu Agrawal
Professor,
University of California, Irvine
.jpg?length=600&name=Shrivastav%20Pic%20(2).jpg)
Anuraag Shrivastav
President,
Oncodrex

David Weingeist
Scientific Director, Oncology Precision Medicine & Diagnostics,
Johnson & Johnson

Jadwiga Bienkowska
Senior Director,
Pfizer

Jonathan Sims
Senior Director,
Eli Lilly and Company

Joseph McDermott
Computational Biologist,
Lantern Pharma

KC Hart
Clinical Biomarker Lead,
IGM Biosciences

Manoj Kandpal
Director of Research Bioinformatics,
The Rockefeller University

Matthias von Herrath
Vice President & Senior Medical Officer, Global Chief Medical Office,
Novo Nordisk
.jpg?length=600&name=Rawan%20Tarawneh_headshot%202024%20(1).jpg)
Rawan Tarawneh
Associate Professor, School of Medicine, Department of Neurology,
University of New Mexico

Ruchi Gupta
Head of Biomarkers,
Alector Inc.

Soumya Poddar
Associate Director, Translational Sciences,
Gilead Sciences

Sripad Ram
Digital Pathology and Image Analysis Lead,
Pfizer Inc

Vitalay Fomin
Chief Executive Officer,
Numenos

Xuemei Zhao
Senior Principal Scientist,
Merck & Co., Inc.

Yiming Zhu
Senior Director, Biomarker Sciences,
Avidity Biosciences

Espen Walker
Global Head Medical Diagnostics,
AstraZeneca

Marcus Otte
Senior Director, Head of Clinical Biomarker and Technologies,
Merck Healthcare KGaA

Maria Orr
Head of Precision Medicine and Biosamples, Early Oncology,
AstraZeneca

Matt Brown
Chief Scientific Officer,
Genomics England

Professor Sir Mark Caulfield
Vice Principal for Health,
Queen Mary’s Faculty of Medicine and Dentistry

Sushma Iyengar
Senior Director, Global Regulatory Affairs, Precision Medicine & Digital Health,
Takeda

Svetlana Mukhina
Director Global Regulatory Affairs, Global Regulatory Affairs CDx,
Merck Group

Alain Van Gool
Professor Personalized Healthcare,
Radboud University Medical Center
Antonina Mitrofanova
Associate Professor and Associate Dean for Research,
Rutgers Health, SHP

Belinda Nedjai
Reader/ Associate Professor in cancer biomarker and Epigenetic,
Queen Mary University Of London

Chris Bray
Head Global Regulatory Affairs, Precision Medicine & Companion Diagnostics,
Merck Healthcare KGaA

Daniel Strasser
Director, Therapeutic Area Biomarker Lead / Biomarker Strategy Immunology,
Novartis

Emanuela Oldoni
Scientific Programme Manager- Biomarkers,
EATRIS

Emmanuel Valentin
Vice President, Translational Medicine,
Imcheck Therapeutics

Gayle Marshall
Head of Biomarkers,
Catapult Medicines Discovery

Giovanna Lalli
Director, Strategy & Operations,
LifeArc

Harpreet Saini
Senior Director Bioinformatics,
Astex Pharmaceuticals

Helen Graves
Principal Scientist,
Alchemab Therapeutics

Irene Del Molino del Barrio
Principal Scientist,
GSK

Jens Kieckbusch
Director, External Innovation Precision Medicine,
GlaxoSmithKline

Jim Eyles
Director, Clinical Immuno-Oncology Discovery Group,
AstraZeneca
Jimmy Bell
Professor,
University of Westminster
Jo Taylor
Founder,
METUPUK
Joanna Janus
Research Programme Manager,
Cancer Research UK

Johan Luthman
Executive Vice President & Head of Research & Development,
Lundbeck

Karl Smith-Byrne
Senior Molecular Epidemiologist,
Centre for Medicines Discovery

Katherine Freeman
Senior Portfolio Manager, Digital Health,
UK Research Councils

Kiri Granger
Chief Scientific Officer,
Monument Therapeutics

Laurent Audoly
CEO, Co-Founder,
PriveBio

Lindsay Darling
Director, Companion Diagnostics Portfolio Management & Operations,
Regeneron

Liz Harrington
Executive Director, Translational Medicine Global Head of Targeted Therapy Franchise (TDE),
ASTRAZENECA
Mani Mudaliar
Director, Quantitative Biomarkers,
Recursion

Manuela Cerina
Scientific Director of Neurodegeneration,
LifeArc
Maria Laura Garcia Bermejo
Scientific Director,
Ramon y Cajal Health Research Institute (IRYCIS)
Michael Zaiac
Head of Medical Affairs Oncology Region Europe,
Daiichi Sankyo
Michael Cannarile
Head of Oncology Biomarkers,
China Innovation Center of Roche

Mike Messenger
Head of Regulatory Strategy,
BIVDA

Miro Venturi
Operating Partner,
ARCHIMED

Nathalie Banner
Director of Ethics,
Genomics England

Neil Humphryes-Kirilov
Associate Director of Human Genomics,
C4X Discovery
.jpg?length=600&name=3bb203aa-c4df-434c-9eb3-a974fad3766c-2-11764368speaker_photo-1516569446425-(2).jpg)
Nitin Jain
Director, Franchise Project Management,
ASTRAZENECA

Olga Nissan
Chief Executive Officer,
Protica Bio

Peter Groenen
Head of Translational Science,
Cerebrum DAO

Roya Esat Dabestani
Precision Medicine Lead,
Innovate UK Business Connect

Thomas Jensen
Chief Executive Officer,
Allarity Therapeutics

Thomas Hach
Global Program Clinical Head,
Novartis

Valerie Taly
Group Leader,
University of Paris Descartes

Victoria Goss
Head of Early Diagnosis and Translational Group,
University of Southampton

Vihanga Pahalawatta
Director - Regulatory Affairs Companion Diagnostics,
AbbVie

Wanderson Dos Santos Trindade
Director Global Regulatory Affairs - Companion Diagnostics,
Daiichi-Sankyo